For the quarter ending 2025-09-30, CRWV had $915,108K increase in cash & cash equivalents over the period. -$699,754K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -110,124 | -605,150 |
| Depreciation and amortization | 630,479 | 1,002,978 |
| Non-cash lease expense | 89,723 | 144,113 |
| Amortization of debt discounts and issuance costs and accretion of redemption premiums | 21,049 | 66,727 |
| Loss (gain) on fair value adjustments | 0 | 26,837 |
| Stock-based compensation | 144,431 | 328,978 |
| Debt extinguishment loss | -14,486 | - |
| Deferred income taxes | -128,025 | 90,884 |
| Other non-cash reconciling items | 9,256 | 40,132 |
| Accounts receivable | -252,189 | 1,504,696 |
| Prepaid expenses and other current assets | 50,586 | 120,448 |
| Accounts payable and accrued expenses | 622,384 | -289,173 |
| Deferred revenue | 659,272 | 742,892 |
| Lease liabilities | -70,610 | -110,451 |
| Other non-current assets | 394,790 | -49,968 |
| Other liabilities | 0 | - |
| Net cash provided by operating activities | 1,689,134 | -190,083 |
| Purchase of property and equipment, including capitalized internal-use software | 2,388,888 | 3,860,351 |
| Sale of available-for-sale marketable securities | 0 | 0 |
| Maturities of marketable securities | 0 | 29,308 |
| Purchase of marketable securities | 47,246 | 0 |
| Purchase of strategic investments | 0 | 0 |
| Sale of warrants received as lease incentive | 0 | 100,645 |
| Business combinations, net of cash acquired | 10,212 | 45,706 |
| Issuance of notes receivable | 0 | 73,000 |
| Other investing activities | 23,740 | 26,109 |
| Net cash used in investing activities | -2,470,086 | -3,875,213 |
| Proceeds from issuance of debt | 3,129,963 | 4,432,723 |
| Repayments of debt | 1,403,983 | 1,574,867 |
| Payment of debt issuance costs | 9,550 | 36,536 |
| Issuance of redeemable convertible preferred stock, net of issuance costs | 0 | 0 |
| Redeemable convertible preferred stock cash dividends paid | 0 | 28,693 |
| Proceeds from exercise of stock options | 12,981 | 4,538 |
| Proceeds from initial public offering, net of underwriting discounts and commissions | 0 | 1,422,619 |
| Issuance of common stock in connection with over-allotment exercise, net of underwriting discounts and commissions | 0 | 67,669 |
| Payment of tax withholdings on settlement of rsus | 11,485 | 132,558 |
| Deferred offering costs paid | 1,006 | 27,763 |
| Common stock repurchased | 0 | - |
| Other financing activities | -20,860 | -44,086 |
| Net cash provided by financing activities | 1,696,060 | 4,083,046 |
| Net increase in cash, cash equivalents, and restricted cash | 915,108 | 17,750 |
| Cash and cash equivalents at beginning of period | 2,035,833 | - |
| Cash and cash equivalents at end of period | 2,968,691 | - |
CoreWeave, Inc. (CRWV)
CoreWeave, Inc. (CRWV)